Search

Your search keyword '"Carrier, Lucie"' showing total 702 results

Search Constraints

Start Over You searched for: Author "Carrier, Lucie" Remove constraint Author: "Carrier, Lucie"
Sorry, I don't understand your search. ×
702 results on '"Carrier, Lucie"'

Search Results

2. Western diet triggers cardiac dysfunction in heterozygous Mybpc3-targeted knock-in mice: A two-hit model of hypertrophic cardiomyopathy

Catalog

Books, media, physical & digital resources

3. Abstract 12927: Impact of AAV-MYBPC3 Gene Transfer on Heart Structure and Function in Human and Mouse Models of Hypertrophic Cardiomyopathy

5. Chronic Activation of Tubulin Tyrosination Improves Heart Function.

6. Cas9-expressing chickens and pigs as resources for genome editing in livestock

8. Translational investigation of electrophysiology in hypertrophic cardiomyopathy

9. Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

14. Broad therapeutic benefit of myosin inhibition in hypertrophic cardiomyopathy

16. Targets for therapy in sarcomeric cardiomyopathies

18. Mechanistic role of the CREB-regulated transcription coactivator 1 in cardiac hypertrophy

19. RNA Editing Holds Promise for Hypertrophic Cardiomyopathy Therapy.

22. Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy

24. EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy

27. Nitro-fatty acids suppress ischemic ventricular arrhythmias by preserving calcium homeostasis

30. Animal models and animal-free innovations for cardiovascular research

31. Reducing microtubule detyrosination improves heart function in HCM mice and human iPSC-engineered heart tissues

35. Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

39. Modelling LMNA-cardiomyopathy with patient-specific human iPSC-derived engineered heart tissue and a partial rescue by gene replacement therapy

42. Functional characterisation of a patient-derived laminopathy model in human engineered heart tissues recapitulates fibrosis and mechanical decoupling defect

45. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: From molecular mechanisms to therapeutic targets

46. ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes

49. Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-mediated Calcium Signaling and Arrhythmias in the Heart Evoked by β-Adrenergic Stimulation